These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35766348)

  • 1. Alcohol misuse in patients with alcohol-related liver disease: How can we do better? A narrative review of the literature.
    Horrell J; Callaghan L; Dhanda A
    Alcohol Clin Exp Res; 2022 Aug; 46(8):1364-1370. PubMed ID: 35766348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of severe alcohol related liver disease over four decades in Iceland: impact of increased access and use of alcohol.
    Björnsson ES; Johannsson A; Sigurdarson SS; Hreinsson JP; Runarsdottir V
    Scand J Gastroenterol; 2023; 58(12):1523-1533. PubMed ID: 37551903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of psychosocial interventions to reduce alcohol use in comorbid alcohol use disorder and alcohol-related liver disease: a systematic review of randomized controlled trials.
    Hemrage S; Brobbin E; Deluca P; Drummond C
    Alcohol Alcohol; 2023 Sep; 58(5):478-484. PubMed ID: 37530582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Australian guidelines for the treatment of alcohol problems: an overview of recommendations.
    Haber PS; Riordan BC; Winter DT; Barrett L; Saunders J; Hides L; Gullo M; Manning V; Day CA; Bonomo Y; Burns L; Assan R; Curry K; Mooney-Somers J; Demirkol A; Monds L; McDonough M; Baillie AJ; Clark P; Ritter A; Quinn C; Cunningham J; Lintzeris N; Rombouts S; Savic M; Norman A; Reid S; Hutchinson D; Zheng C; Iese Y; Black N; Draper B; Ridley N; Gowing L; Stapinski L; Taye B; Lancaster K; Stjepanović D; Kay-Lambkin F; Jamshidi N; Lubman D; Pastor A; White N; Wilson S; Jaworski AL; Memedovic S; Logge W; Mills K; Seear K; Freeburn B; Lea T; Withall A; Marel C; Boffa J; Roxburgh A; Purcell-Khodr G; Doyle M; Conigrave K; Teesson M; Butler K; Connor J; Morley KC
    Med J Aust; 2021 Oct; 215 Suppl 7():S3-S32. PubMed ID: 34601742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal screening for alcohol misuse in acute medical admissions is feasible and identifies patients at high risk of liver disease.
    Westwood G; Meredith P; Atkins S; Greengross P; Schmidt PE; Aspinall RJ
    J Hepatol; 2017 Sep; 67(3):559-567. PubMed ID: 28756907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current treatment options for alcohol-related liver disease.
    Hazeldine S; Sheron N
    Curr Opin Gastroenterol; 2014 May; 30(3):238-44. PubMed ID: 24662843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of alcohol care teams on emergency secondary care use following a diagnosis of alcoholic liver disease - a national cohort study.
    Currie C; Davies A; Ariti C; Bardsley M
    BMC Public Health; 2016 Aug; 16():685. PubMed ID: 27484915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history of alcohol-related liver disease.
    Parker R
    Curr Opin Gastroenterol; 2020 May; 36(3):164-168. PubMed ID: 32073504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis.
    Niu X; Zhu L; Xu Y; Zhang M; Hao Y; Ma L; Li Y; Xing H
    BMC Public Health; 2023 May; 23(1):859. PubMed ID: 37170239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Liverpool alcohol-related liver disease algorithm identifies twice as many emergency admissions compared to standard methods when applied to Hospital Episode Statistics for England.
    Dhanda A; Bodger K; Hood S; Henn C; Allison M; Amasiatu C; Burton R; Cramp M; Forrest E; Khetani M; MacGilchrist A; Masson S; Parker R; Sheron N; Simpson K; Vergis N; White M;
    Aliment Pharmacol Ther; 2023 Feb; 57(4):368-377. PubMed ID: 36397658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AlcoChange: A digital therapeutic for patients with alcohol-related liver disease.
    Mehta G; Lin S; Nadar A; Pv B; Kumar R; Balaji A; Macdonald S; Sheikh MF; Saeidinejad M; Sharma SR; King JJ; Mookerjee RP; McDonagh L; Afuwape SA; Moore K; Jalan R
    JHEP Rep; 2024 Apr; 6(4):100993. PubMed ID: 38425452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proactive case finding of alcohol-related liver disease in high-risk populations: A systematic review.
    Archer AJ; Phillips J; Subhani M; Ward Z; Gordon FH; Hickman M; Dhanda AD; Abeysekera KWM
    Liver Int; 2024 Jun; 44(6):1298-1308. PubMed ID: 38456654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mental Imagery to Reduce Alcohol-related harm in patients with alcohol dependence and alcohol-related liver damaGE: the MIRAGE pilot trial protocol.
    Dhanda AD; Allende H; Allgar V; Andrade J; Bailey MP; Callaghan L; Cocking L; Goodwin E; Hawton A; Hayward C; Hudson B; Jeffery A; King A; Lavers V; Lomax J; McCune CA; Parker R; Rollinson C; Wilks J; Creanor ES
    BMJ Open; 2022 May; 12(5):e060498. PubMed ID: 35584873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there scope to improve the selection of patients with alcohol-related liver disease for referral to secondary care? A retrospective analysis of primary care referrals to a UK liver centre, incorporating simple blood tests.
    Rhodes FA; Cococcia S; Patel P; Panovska-Griffiths J; Tanwar S; Westbrook RH; Rodger A; Rosenberg W
    BMJ Open; 2021 Jun; 11(6):e047786. PubMed ID: 34088709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Hospital Discharges with Alcohol-Related Liver Disease in a Gastroenterology and General Medical Unit Following the Introduction of Minimum Unit Pricing of Alcohol: The GRI Q4 Study.
    Chaudhary S; MacKey W; Duncan K; Forrest EH
    Alcohol Alcohol; 2022 Jul; 57(4):477-482. PubMed ID: 34343256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental Imagery to Reduce Alcohol-related harm in patients with alcohol use disorder and alcohol-related liver damaGE: the MIRAGE randomised pilot trial results.
    Dhanda A; Andrade J; Allende H; Allgar V; Bailey M; Callaghan L; Cocking L; Goodwin E; Hawton A; Hayward C; Hudson B; Ingram W; Jeffery A; King A; Lavers V; Lomax J; McCune CA; Musicha C; Parker R; Rollinson C; Wilks J; Creanor ES
    BMJ Open Gastroenterol; 2024 Jan; 11(1):. PubMed ID: 38286518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver Transplantation for Alcohol-Related Liver Disease (ARLD): An Update on Controversies and Considerations.
    Yadav DK; Zhang Q; Bai X; Li E; Liang T
    Can J Gastroenterol Hepatol; 2020; 2020():8862152. PubMed ID: 33014915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver Transplantation for Alcoholic Liver Disease: What Is the Risk and Consequence of Relapse?
    Neuberger J
    Dig Dis Sci; 2020 Jun; 65(6):1600-1607. PubMed ID: 32060813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol-related liver disease mortality and missed opportunities in secondary care: A United Kingdom retrospective observational study.
    Subhani M; Elleray R; Bethea J; Morling JR; Ryder SD
    Drug Alcohol Rev; 2022 Sep; 41(6):1331-1340. PubMed ID: 35640649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare interactions prior to first hospital admission with alcohol-related liver disease.
    Lewis H; Parker R; Ul-Haq Z; Lucas A; Cohen C; Vergis N; Thursz M
    Liver Int; 2024 May; ():. PubMed ID: 38771187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.